Meeting Banner
Abstract #0629

Deuterated choline tracks choline kinase α activity and enables non-invasive assessment of response to therapy in gliomas in vivo.

Celine Taglang1, Georgios Batsios1, Meryssa Tran1, Anne-Marie Gillespie1, Sabrina Ronen1, and Pavithra Viswanath1
1Radiology, University of California San Francisco, San Francisco, CA, United States


Elevated choline phospholipid metabolism is a hallmark of cancer. Here, we show that silencing choline kinase a (CKα), the rate-limiting enzyme in choline phospholipid biosynthesis, abrogates total choline (tCho) production from [2H9]-choline in patient-derived glioma models, indicating that tCho production from [2H9]-choline predominantly reflects CKα activity. Importantly, we show that [2H9]-choline metabolism to tCho serves to delineate tumor from normal brain in mice bearing orthotopic patient-derived low-grade gliomas. Furthermore, [2H9]-choline informs on response to therapy, at early timepoints when anatomical alterations cannot be detected, pointing to the ability of [2H9]-choline to assess pseudoprogression, which is a challenge in glioma imaging.

This abstract and the presentation materials are available to members only; a login is required.

Join Here